Both in Biotechnology
Palisade Bio vs Artiva Biotherapeutics
Over the past year PALI returned −44.0% and ARTV returned +11.1%; their daily moves had a correlation of 0.20.
PALI −44.0% ARTV +11.1%Growth of $1, one year, split-adjusted
| Metric | PALI | ARTV |
|---|---|---|
| Price | $1.12 | $4.19 |
| Market cap | $195.2M | $204.8M |
| Today | −3.45% | 0.00% |
| 1 month | −22.2% | −38.7% |
| 6 months | −47.4% | −62.9% |
| Year to date | −52.3% | −2.3% |
| 1 year | −42.3% | +6.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −2114.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 390.4× | — |
| Net cash | $125.2M | $349.4M |
| Dividend yield | — | — |
| Volatility (60d) | 75.4% | 93.2% |
| Short % of float | 18.3% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).